Eribal v. Janssen Research & Development, LLC et al

Filing 5

MDL ORDER. CASE TRANSFERRED to the Eastern District of Louisiana. CASE CLOSED. (Donati, J)

Case Case MDL No. 2592 Document 241 Filed 02/18/15 Page Page 1 of 3
2:14-md-02592-EEF-MBN Document 204 Filed 02/18/15 1 of 3

UNITED STATES JUDICIAL PANEL
on
MULTIDISTRICT LITIGATION

IN RE: XARELTO (RIVAROXABAN)
PRODUCTS LIABILITY LITIGATION

FEB 20 2015
Feb 18 2015

MDL No. 2592

(SEE ATTACHED SCHEDULE)

FILED
Feb 26, 2015
CLERK, U.S. DISTRICT COURT
EASTERN DISTRICT OF CALIFORNIA

CONDITIONAL TRANSFER ORDER (CTO 14)

On December 12, 2014, the Panel transferred 20 civil action(s) to the United States District Court
for the Eastern District of Louisiana for coordinated or consolidated pretrial proceedings pursuant to
28 U.S.C. § 1407. See _F.Supp.2d_ (J.P.M.L. 2014). Since that time, 130 additional action(s) have
been transferred to the Eastern District of Louisiana. With the consent of that court, all such actions
have been assigned to the Honorable Eldon E Fallon.
It appears that the action(s) on this conditional transfer order involve questions of fact that are
common to the actions previously transferred to the Eastern District of Louisiana and assigned to
Judge Fallon.
Pursuant to Rule 7.1 of the Rules of Procedure of the United States Judicial Panel on Multidistrict
Litigation, the action(s) on the attached schedule are transferred under 28 U.S.C. § 1407 to the
Eastern District of Louisiana for the reasons stated in the order of December 12, 2014, and, with the
consent of that court, assigned to the Honorable Eldon E Fallon.
This order does not become effective until it is filed in the Office of the Clerk of the United States
District Court for the Eastern District of Louisiana. The transmittal of this order to said Clerk shall
be stayed 7 days from the entry thereof. If any party files a notice of opposition with the Clerk of the
Panel within this 7 day period, the stay will be continued until further order of the Panel.

FOR THE PANEL:

Feb 18, 2015

Jeffery N. Lüthi
Clerk of the Panel

Case Case MDL No. 2592 Document 241 Filed 02/18/15 Page Page 2 of 3
2:14-md-02592-EEF-MBN Document 204 Filed 02/18/15 2 of 3

IN RE: XARELTO (RIVAROXABAN)
PRODUCTS LIABILITY LITIGATION

MDL No. 2592

SCHEDULE CTO 14

DIST

DIV.

TAG ALONG ACTIONS

C.A.NO.

CASE CAPTION

15
15
15
15
15
15

Soto v. Janssen Research & Development, LLC et al
Busby v. Janssen Research & Development, LLC, et al.
Eribal v. Janssen Research & Development, LLC et al
Sullivan v. Janssen Research & Development, LLC et al
Minz v. Janssen Research & Development, LLC et al
Dagley v. Janssen Research & Development, LLC et al

CALIFORNIA EASTERN
CAE
CAE
CAE
CAE
CAE
CAE

1
1
2
2
2
2

00166
00169
00259
00262
00263
00265

CONNECTICUT
CT

3

15 00129

Smith v. Janssen Research & Development LLC et al

15 00135

MERRELL v. JANSSEN RESEARCH , et al.

5

15 00217

Dowell v. JANSSEN RESERACH AND
DEVELOPMENT LLC et al

3

15 00649

BRITTON et al v. JANSSEN RESEARCH &
DEVELOPMENT LLC et al

15 00455

Hartman et al v. Janssen Research & Development LLC
f/k/a Johnson and Johnson Pharmaceutical Research and
Development LLC et al

INDIANA SOUTHERN
INS

1

LOUISIANA WESTERN
LAW
NEW JERSEY
NJ

NEW YORK EASTERN
NYE

2

NEW YORK SOUTHERN
NYS

1

15 00610

Agans et al v. Janssen Research & Development LLC et
al

Case Case MDL No. 2592 Document 241 Filed 02/18/15 Page Page 3 of 3
2:14-md-02592-EEF-MBN Document 204 Filed 02/18/15 3 of 3
NYS

1

15 00611

Potter et al v. Janssen Research & Development LLC et
al

PENNSYLVANIA EASTERN
PAE

2

15 00450

PAE

2

15 00476

POVILAITIS v. JANSSEN RESEARCH &
DEVELOPMENT, LLC et al
HETTEL v. JANSSEN RESEARCH &
DEVELOPMENT LLC et al